Search

everythinglearnresearchcommunity

for

Search:↓

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Dermoscopy now helps diagnose various skin, hair, and nail issues, improving patient care and treatment understanding.

Small molecule IM boosts hair growth by changing stem cell metabolism.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Metformin helped improve the quality of life for Chinese women with PCOS, especially in physical health and symptoms like infertility, acne, and hair loss.

Moderately high prolactin levels do not cause hair loss in women.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Acne lesions start with changes in hair follicles and increase in inflammation, suggesting a cycle that could affect treatment strategies.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

3D cell-derived matrices improve tissue regeneration and disease modeling.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.